ECSP21042779A - MODULATORS OF IRF5 EXPRESSION - Google Patents

MODULATORS OF IRF5 EXPRESSION

Info

Publication number
ECSP21042779A
ECSP21042779A ECSENADI202142779A ECDI202142779A ECSP21042779A EC SP21042779 A ECSP21042779 A EC SP21042779A EC SENADI202142779 A ECSENADI202142779 A EC SENADI202142779A EC DI202142779 A ECDI202142779 A EC DI202142779A EC SP21042779 A ECSP21042779 A EC SP21042779A
Authority
EC
Ecuador
Prior art keywords
modulators
irf5
expression
irf5 expression
useful
Prior art date
Application number
ECSENADI202142779A
Other languages
Spanish (es)
Inventor
Susan M Freier
Original Assignee
Ionis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ionis Pharmaceuticals Inc filed Critical Ionis Pharmaceuticals Inc
Publication of ECSP21042779A publication Critical patent/ECSP21042779A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Las presentes modalidades proporcionan métodos, compuestos, y composiciones útiles para inhibir la expresión de IRF5, que pueden ser útiles para tratar, prevenir o mejorar una enfermedad asociada con el IRF5.The present embodiments provide methods, compounds, and compositions useful for inhibiting IRF5 expression, which may be useful for treating, preventing, or ameliorating IRF5-associated disease.

ECSENADI202142779A 2020-11-15 2021-06-11 MODULATORS OF IRF5 EXPRESSION ECSP21042779A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202062767615P 2020-11-15 2020-11-15

Publications (1)

Publication Number Publication Date
ECSP21042779A true ECSP21042779A (en) 2021-09-30

Family

ID=80777762

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202142779A ECSP21042779A (en) 2020-11-15 2021-06-11 MODULATORS OF IRF5 EXPRESSION

Country Status (1)

Country Link
EC (1) ECSP21042779A (en)

Similar Documents

Publication Publication Date Title
NI202100018A (en) MODULATORS OF PNPLA3 EXPRESSION
CO2018003168A2 (en) Kras expression modulators
UY38613A (en) PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE OF THE SAME
CO2017013065A2 (en) Diaciglycerol acyltransferase 2 modulators (dgat2)
CO2021007006A2 (en) Modulators of irf5 expression
NI202000085A (en) MODULATORS OF APOL1 EXPRESSION
CR20190471A (en) Modulators of pcsk9 expression
CO2021008816A2 (en) Trex1 modulators
ECSP21053104A (en) HSD17B13 EXPRESSION MODULATORS
PE20210109A1 (en) IRF4 EXPRESSION MODULATORS
CO2020008769A2 (en) Modulators of the dnm2 expression
CO2020003134A2 (en) Modulators of enac expression
UY38472A (en) FOXP3 EXPRESSION MODULATORS
ECSP21042779A (en) MODULATORS OF IRF5 EXPRESSION
CL2022002684A1 (en) Anti-cd6 antibody compositions and methods for treating and reducing negative effects of a coronavirus
AR117079A1 (en) FOXP3 EXPRESSION MODULATORS
CO2023012852A2 (en) Tyrosinase inhibitor molecules and dermopharmaceutical or cosmetic composition that includes them
EA202191657A1 (en) EXPRESSION MODULATORS HSD17B13